Christopher Richard Hibberd

Christopher Richard Hibberd

Amministratore Delegato presso Nucleix Ltd.

Health Technology
Consumer Services
Commercial Services

Profilo

Christopher Richard Hibberd is the founder of Astute Medical, Inc., which was founded in 2007.
He held the title of Chief Executive Officer & Director at Astute Medical, Inc. Mr. Hibberd is currently the Executive Chairman & Chief Executive Officer at Nucleix Ltd.
since 2019 and the Director at MeMed Diagnostics Ltd.
since 2020.
In his former positions, he was a Non-Executive Director at Oxford BioTherapeutics Ltd., Senior Vice President-Corporate Development at Alere San Diego, Inc., and a Manager at The Boston Consulting Group, Inc. He also worked as a Development Engineer at Albright & Wilson Americas, Inc. from 1987 to 1990.
Mr. Hibberd received his undergraduate degree from the University of Toronto and his MBA from the University of Western Ontario.

Posizioni attive di Christopher Richard Hibberd

SocietàPosizioneInizio
Amministratore Delegato 11/05/2020
Direttore/Membro del Consiglio 16/12/2020
Tutte le posizioni attive di Christopher Richard Hibberd

Precedenti posizioni note di Christopher Richard Hibberd

SocietàPosizioneFine
Corporate Officer/Principal 01/01/1990
Corporate Officer/Principal -
Direttore/Membro del Consiglio -
Fondatore -
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Christopher Richard Hibberd

Formazione di Christopher Richard Hibberd

University of Western Ontario Masters Business Admin
University of Toronto Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Christopher Richard Hibberd

Relazioni

23

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private7

Commercial Services

Electronic Technology

Health Technology

Health Technology

Health Services

Health Technology

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Christopher Richard Hibberd